Speaker(s): 
Hailey Knittle, PharmD and Morgan Casciole, PharmD, MBA, Geisinger Pharmacy Residents have nothing to disclose.

Moderator(s): 
Adriene Zook, PharmD, RPH, Geisinger Pharmacy, have nothing to disclose.

Learning Objectives: 
At the conclusion of this session, the participant should be able to: 

1.    Summarize new lifestyle updates for the prevention and treatment of diabetes mellitus as published in the 2024 ADA Standards of Care guideline
2.    Review updated recommendations regarding the use of diabetes technology
3.    Explain the changes to recommendations regarding diabetes and special populations

Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Stacy Coolbaugh, MBA, RDN, LDN; Angela Esherick, RDN, LDN, CDCES; Adriene Zook, PharmD, RPH, Dan Huston, DNP, RN, BC-ADM, and Angela Zammit have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 
This presentation/content is HIPPA compliant. 

Session date: 
02/20/2024 - 12:00pm to 1:00pm EST
Location: 
Virtual using Microsoft Teams
Danville, PA 17822
United States
  • 1.00 ACPE
  • 1.00 ANCC
  • 1.00 CDR
  • 1.00 Participation Credit

Please login or register to take this course.